We are pleased to be featured as #SMEoftheWeek on Digital Health London Accelerator social channels
- pahini5
- Jul 28, 2022
- 1 min read
They highlight how Panakeia is changing the way biomarker testing is done through the use of #AI. Read more...
top of page
Search
Cambridge, UK, 9 April 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...
PANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...
bottom of page
Comments